Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

For Life Sciences, There’s No Time to Waste

9,703 views

Published on

New technologies now allow life sciences companies to pursue “outcomes-based” commercial models that directly tie their reimbursements to the real-world outcomes their patients' experience. Those companies that embrace the outcomes-based commercial opportunity early will have the best chance of not only regaining control of key profitability levers, but also influencing the industry’s shift to a healthier financial model.

Published in: Technology
  • Be the first to comment

  • Be the first to like this

For Life Sciences, There’s No Time to Waste

  1. 1. Copyright © 2017 Accenture All rights reserved. Accenture, its logo, and High Performance Delivered are trademarks of Accenture.
  2. 2. Copyright © 2017 Accenture All rights reserved. Accenture, its logo, and High Performance Delivered are trademarks of Accenture. LIFE SCIENCES COMPANIES HAVE NO TIME TO WASTE In 2015-2016, United States’ governing bodies proposed 46 distinct bills to legislate drug pricing.
  3. 3. Copyright © 2017 Accenture All rights reserved. Accenture, its logo, and High Performance Delivered are trademarks of Accenture. THE INDUSTRY FACES A CRITICAL CHOICE: Stick with the traditional commercial model and face steady economic compression from regulators and market forces. Embrace outcomes-based care to regain control of profitability levers and steer the industry to a healthier financial model. OR
  4. 4. Copyright © 2017 Accenture All rights reserved. Accenture, its logo, and High Performance Delivered are trademarks of Accenture. OUTCOMES-BASED CARE DIGITALLY POWERS BETTER HEALTH MARKETS New technologies allow life sciences companies to directly tie reimbursements to patients’ real-world outcomes. • Wearables,the Internetof Things,artificial intelligence,andmobile platforms enable more targeted, secure, and responsive patient interventions. • Predictive real-worldanalytics efficiently coordinate patients’ care with providers and relevant services. • Fair market-value of treatmentsis ensured via collection, analysis, and application of patients’ health data.
  5. 5. Copyright © 2017 Accenture All rights reserved. Accenture, its logo, and High Performance Delivered are trademarks of Accenture. OUTCOMES-BASED MODELS GROWTH OPPORTUNITIES: Short-Term • Oncology • Viral hepatitis • Diabetes Future • Respiratory • Autoimmune areas
  6. 6. Copyright © 2017 Accenture All rights reserved. Accenture, its logo, and High Performance Delivered are trademarks of Accenture. IT’S TIME TO PLAY OFFENSE, NOT DEFENSE In order to capitalize on the evolving outcomes-based commercial opportunity, life sciences companies must: • Increase digital capabilities.Almost all life sciences companies currently lack the digital tools they need to define, measure, and control patient outcomes. • Advocate reshapingthe market. Companies must vocally engage regulatory bodies to reform fair market value, legal frameworks and “best price” considerations. • Developa new “outcomes-based” mindset: Health care reinvention requires constructing an ecosystem of like- minded partners, providers and customers seeking to drive results-oriented value at every turn.
  7. 7. Copyright © 2017 Accenture All rights reserved. Accenture, its logo, and High Performance Delivered are trademarks of Accenture. A WORLDWIDE HEALTH REVOLUTION Falling technology costs will open up outcomes-based care opportunities around the world. First movers will define patients’ health care and industry profitability for years to come. Life science companies have no time to waste.
  8. 8. Copyright © 2017 Accenture All rights reserved. Accenture, its logo, and High Performance Delivered are trademarks of Accenture. Learn more about how outcomes-based models will transform the future of health care with our full report: @AccentureStrat No Time To Waste JOIN THE CONVERSATION: @AccentureLifSci https://www.linkedin.com/company/accenture-strategy https://www.linkedin.com/showcase/10331490/

×